NCT00184769 - Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 29, 1998

Primary Completion Date

December 21, 2005

Study Completion Date

December 21, 2005

Conditions

Chronic Kidney DiseaseChronic Renal Insufficiency

Interventions

DRUG

somatropin

Trial Locations (20)

15705

Novo Nordisk Investigational Site, Santiago de Compostela

27004

Novo Nordisk Investigational Site, Lugo

28009

Novo Nordisk Investigational Site, Madrid

28041

Novo Nordisk Investigational Site, Madrid

28046

Novo Nordisk Investigational Site, Madrid

29011

Novo Nordisk Investigational Site, Málaga

31008

Novo Nordisk Investigational Site, Pamplona

33006

Novo Nordisk Investigational Site, Oviedo

38010

Novo Nordisk Investigational Site, Santa Cruz de Tenerife

39008

Novo Nordisk Investigational Site, Santander

41013

Novo Nordisk Investigational Site, Seville

48903

Novo Nordisk Investigational Site, Barakaldo

50009

Novo Nordisk Investigational Site, Zaragoza

3000-075

Novo Nordisk Investigational Site, Coimbra

1160-045

Novo Nordisk Investigational Site, Lisbon

1649-035

Novo Nordisk Investigational Site, Lisbon

4200-319

Novo Nordisk Investigational Site, Porto

06080

Novo Nordisk Investigational Site, Badajoz

08950

Novo Nordisk Investigational Site, Esplugues Llobregat

Unknown

Novo Nordisk Investigational Site, San Sebastián